Halozyme
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
12390 El Camino Real, San Diego, Califor...Phone Number
(858) 794-8889Website
www.halozyme.comRevenue
$1.5 BillionStock Symbol
HALOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Halozyme
Halozyme Inc. is an American biotechnology and biopharmaceutical company specializing in the development and commercialization of advanced drug delivery technologies and enzyme-based therapeutic solutions. The organization focuses primarily on improving the administration of biologic medicines through proprietary technologies that enable subcutaneous drug delivery for therapies that traditionally require intravenous infusion. Through scientific innovation, strategic pharmaceutical partnerships, and proprietary platform technologies, the company has established a significant position within the global biotechnology and pharmaceutical ecosystem. The company was founded in San Diego, California and has evolved into a globally recognized biotechnology enterprise with extensive collaborations across the pharmaceutical industry. Halozymes business model combines internal therapeutic development with technology licensing arrangements that allow pharmaceutical partners to integrate Halozymes pRead more
Halozyme Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Halozyme your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Halozyme is spiking on competitors!
Product Launch: Get notified when Halozyme launches new products
Funding: Get notified immidiatlly once Halozyme has new funding data
Earning: See what the market has to say on Halozyme recently announced quarterly report
Halozyme, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Halozyme has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Halozyme
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Halozyme had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Halozyme as Masked Content
Find more new buyers
Compare Similar Companies to Halozyme
Compare insights from companies similar to Halozyme, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$19.9M
51-200
Private
$300M
2016
RC
Ryan CarteExecutive Vice President & General Counsel & Corporate Secretary
$18.1M
501-1,000
Public
$100M
2008
NB
Natalie BerwaldExecutive Assistant To the Chief Human Resources Officer
Company Profile Activity
Activity Insights
Halozyme is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Halozyme is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Halozyme.
Halozyme financials insights
Gather financial insights about Halozyme, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Corporate Investment
$5.5M
Stock Offering
$38.2M
2010
Stock Offering
$60M
2012
Stock Offering
$81.8M
2014
Debt
$50M
Stock Offering
$107.8M
2016
Debt
$150M
2017
Stock Offering
$135M
2019
Debt
$400M
Halozyme Tech Stack
A closer look at the technologies used by Halozyme
See more technologies
Most Recent Scoops
Partnership
Project
Partnership, Product Management, Business Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Person-Based
Partnership, Product Development
Event
Product Marketing, Events, Business Intelligence, Analytics & Insights, Sales, Pharmaceuticals, Field /Outside Sales, Field Marketing, Operations, Sales Enablement, Sales Operations
Open Position
Person-Based
Halozyme News & Media
Halozyme’s Partnerships, Earnings Growth See Shares Near All-Time Highs
Halozyme Therapeutics, Inc. (HALO) shares gain 539% since first Big Money outlier inflow signal in March 2014.Halozyme and Incyte sign licence agreement for INCA033989 formulations
The companies aim to enable simplified dosing and delivery methods for patients receiving treatment for MPNs.Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets SAN DIEGO, July 20, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today...Halozyme Appoints David Ramsay as President Drug Delivery
SAN DIEGO, June 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026. In this newly created role, Mr. Ramsay will have an enterprise-wide,...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Halozyme
Sign Up For FreeTo access detailed company insights
Halozyme Inc. is an American biotechnology and biopharmaceutical company specializing in the development and commercialization of advanced drug delivery technologies and enzyme-based therapeutic solutions. The organization focuses primarily on improving the administration of biologic medicines through proprietary technologies that enable subcutaneo... Read More
